This webinar was designed for nurses seeking to expand their knowledge of less common and rare side-effects of immunotherapy in melanoma treatment. While some immunotherapy toxicities are common but manageable, less common and rare side-effects can create additional complexities. This session explored immunotherapy toxicities and presented case studies of less common and rare side-effects, discussing implications for nurses in assessment and management, and gave nurses insights into nurse-led approaches to potentially serious or life-threatening side-effects.
Watch on demand
Event recording
Recording guide
Explore the topics
Open the guide below to see the seven topics covered, then select any topic to open the recording at that point on YouTube in a new tab.
Show the 7 topicsHide the topics
Learning outcomes
What you will learn
After this session, nurses will be able to:
01
Recognise the spectrum of toxicities
Recognise the spectrum of immunotherapy toxicities.
02
Differentiate serious and life-threatening effects
Differentiate between less common but serious and rare but potentially life-threatening side effects.
03
Nursing approaches to assessment and management
Discuss nursing approaches in assessing and managing less common and rare side effects.
04
Patient education tools and language
Equip nurses with tools and language to educate patients on recognising and reporting symptoms.
At a glance
The event in brief
Originally held
Thursday 17 July 2025
Online webinar, part of the Melanoma Nursing Webinar Program.
Who this is for
Nurses
Nurses seeking to expand their knowledge of less common and rare side-effects of immunotherapy in melanoma treatment.
Contributors
Speakers
Speaker
Alethea Lobo
Melanoma Clinical Nurse Consultant, Peter MacCallum Cancer Centre; Co-chair, Melanoma and Skin Cancer Nurses Organisation
Alethea has extensive experience in caring for patients with all stages of melanoma, with a particular focus on the identification and management of treatment toxicities. Alethea is passionate about raising awareness of melanoma and other skin cancers amongst nurses so together they can better support patients.
Speaker
Donna Milne
Clinical Nurse Consultant, Melanoma and Skin Cancer Service, Peter MacCallum Cancer Centre
Donna's main areas of interest include management of immunotherapy and targeted therapy toxicities and supporting and educating patients with advanced cancer and their carers. Donna's PhD examined the perceptions of palliative care held by patients with advanced cancer. She was a founding co-chair of MSCNO, the Melanoma and Skin Cancer Nurses Organisation, and has a Life Fellowship with CNSA.
Keep learning
Further resources
This webinar was brought to you by
Resource details